Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Harvard Bioscience Inc HBIO

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic... see more

Recent & Breaking News (NDAQ:HBIO)

Harvard Bioscience Appoints John Duke to Board of Directors

GlobeNewswire 11 days ago

Harvard Bioscience Announces First Quarter 2025 Financial Results

GlobeNewswire May 12, 2025

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

GlobeNewswire May 5, 2025

Harvard Bioscience Announces CFO Transition

GlobeNewswire April 10, 2025

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

GlobeNewswire March 12, 2025

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

GlobeNewswire March 12, 2025

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

GlobeNewswire February 24, 2025

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

GlobeNewswire February 24, 2025

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESS Newswire January 21, 2025

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

GlobeNewswire January 13, 2025

Harvard Bioscience Announces Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

GlobeNewswire October 29, 2024

Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024

GlobeNewswire October 3, 2024

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting

GlobeNewswire September 18, 2024

Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference

GlobeNewswire September 5, 2024

Harvard Bioscience Announces Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024

Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

GlobeNewswire August 2, 2024

Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

GlobeNewswire June 6, 2024

Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

GlobeNewswire May 23, 2024

Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference

GlobeNewswire May 16, 2024